180 related articles for article (PubMed ID: 35021154)
1. Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma.
Deng B; Chen X; Xu L; Zheng L; Zhu X; Shi J; Yang L; Wang D; Jiang D
Aging (Albany NY); 2022 Jan; 14(1):389-409. PubMed ID: 35021154
[TBL] [Abstract][Full Text] [Related]
2. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
Wu C; Rao X; Lin W
Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
[TBL] [Abstract][Full Text] [Related]
3. Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.
Cyr-Depauw C; Northey JJ; Tabariès S; Annis MG; Dong Z; Cory S; Hallett M; Rennhack JP; Andrechek ER; Siegel PM
Mol Cell Biol; 2016 May; 36(10):1509-25. PubMed ID: 26976638
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
5. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng H; Hang Q; Shen D; Zhang Y; Chen M
Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
[TBL] [Abstract][Full Text] [Related]
6. High expression of PTGES3 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
Gao P; Zou K; Xiao L; Zhou H; Xu X; Zeng Z; Zhang W
Int Immunopharmacol; 2022 Sep; 110():108954. PubMed ID: 35820363
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer.
Pei YF; Zhang YJ; Lei Y; Wu WD; Ma TH; Liu XQ
Oncotarget; 2017 Apr; 8(14):23155-23166. PubMed ID: 28423564
[TBL] [Abstract][Full Text] [Related]
8. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
9. FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma.
Yu Y; Wang Z; Zheng Q; Li J
Aging (Albany NY); 2021 Mar; 13(6):8155-8176. PubMed ID: 33686947
[TBL] [Abstract][Full Text] [Related]
10. RS1 gene is a novel prognostic biomarker for lung adenocarcinoma.
Zhang T; Cheng G; Chen P; Peng Y; Liu L; Li R; Qiu B
Thorac Cancer; 2022 Jun; 13(12):1850-1861. PubMed ID: 35569920
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
13. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
14. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
[TBL] [Abstract][Full Text] [Related]
15. Chordin Like-1 Regulates Osteoblast and Adipocyte Differentiation Through Stabilizing Insulin-Like Growth Factor Binding Protein 3.
Sun H; Wang S; Yang Z; Tian L; Li X; Zhou J; Wang B
Stem Cells; 2023 Apr; 41(4):400-414. PubMed ID: 36682027
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
17. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
18. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
Zhang JT; Lin YC; Xiao BF; Yu BT
Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics identify the role of chordin-like 1 in thyroid cancer.
Yu JW; Pang R; Liu B; Zhang L; Zhang JW
Medicine (Baltimore); 2023 Feb; 102(5):e32778. PubMed ID: 36749222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
